Abstract
Experimental pneumonia was produced with a highly virulent strain of type III pneumococcus which synthesizes, during rapid growth, large amounts of capsular polysaccharide. The type III pneumonia differed from that caused by pneumococcus I in that (a) death occurred more promptly in the type III infection, (b) the local pulmonary lesion became more heavily infected, and (c) frank suppuration was common even after otherwise effective chemotherapy. The greater pathogenicity of the type III organism was shown by special histologic techniques to be due primarily to its capsular slime layer which interferes with surface phagocytosis. Capsular polysaccharide shed from the organism during growth was also demonstrated in high concentration in certain parts of the pneumonic lesion. Removal of the excess polysaccharide from the alveoli resulted from (a) lymphatic drainage to regional lymph nodes and (b) phagocytosis, particularly by macrophages. The possible relationship of the free carbohydrate to the malignancy and the characteristically viscous exudate of type III pneumonia was discussed. The lung abscesses which resulted from type III infection were observed to occur in those areas in which the maximum number of organisms had accumulated. Evidence was obtained that suppuration was due, not to necrotoxic products peculiar to the type III pneumococcus, but rather to the survival of large numbers of bacteria in the tissues, brought about primarily by the antiphagocytic effect of the slime layer. When pneumonia was produced with an intermediate type III mutant lacking the protective slime layer, back mutation to the mucoid parent occurred during the course of the infection, and the mucoid form eventually predominated in the lung as a result of selective phagocytosis of the intermediate organisms. Similar mutation to the maximally virulent type III form was noted with a transformed intermediate type III strain grown from single cell preparations.
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AUSTRIAN R., MacLEOD C. M. A type-specific protein from pneumococcus. J Exp Med. 1949 Apr 1;89(4):439–450. doi: 10.1084/jem.89.4.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dochez A. R., Avery O. T. THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH. J Exp Med. 1917 Oct 1;26(4):477–493. doi: 10.1084/jem.26.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frisch A. W., Price A. E., Myers G. B. TYPE III PNEUMONIA: THE PROGNOSTIC SIGNIFICANCE OF RETICULATION IN RELATION TO THE NUMBER OF PNEUMOCOCCI IN THE SPUTUM, THERAPY, BACTEREMIA, LEUKOCYTE COUNT, AGE, AND DEGREE OF INVOLVEMENT. J Clin Invest. 1943 Mar;22(2):215–220. doi: 10.1172/JCI101385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frisch A. W., Tripp J. T., Barrett C. D., Pidgeon B. E. THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC LUNGS. J Exp Med. 1942 Dec 1;76(6):505–510. doi: 10.1084/jem.76.6.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heidelberger M., Kendall F. E., Scherp H. W. THE SPECIFIC POLYSACCHARIDES OF TYPES I, II, AND III PNEUMOCOCCUS : A REVISION OF METHODS AND DATA. J Exp Med. 1936 Sep 30;64(4):559–572. doi: 10.1084/jem.64.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sale L., Smith M. R., Wood W. B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLANDER'S BACILLUS : II. THE EFFECT OF SULFONAMIDE CHEMOTHERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL FRIEDLANDER'S BACILLUS PNEUMONIA. J Exp Med. 1947 Aug 31;86(3):249–256. doi: 10.1084/jem.86.3.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sale L., Wood W. B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLANDER'S BACILLUS : I. THE PATHOGENESIS OF EXPERIMENTAL FRIEDLANDER'S BACILLUS PNEUMONIA. J Exp Med. 1947 Aug 31;86(3):239–248. doi: 10.1084/jem.86.3.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith M. R., Wood W. B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLADER'S BACILLUS : III. THE ROLE OF "SURFACE PHAGOCYTOSIS" IN THE DESTRUCTION OF THE MICROORGANISMS IN THE LUNG. J Exp Med. 1947 Aug 31;86(3):257–266. doi: 10.1084/jem.86.3.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tripp J. T., Frisch A. W., Barrett C. D., Pidgeon B. E. THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC SPUTA. J Exp Med. 1942 Dec 1;76(6):497–504. doi: 10.1084/jem.76.6.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WOOD W. B., Jr, SMITH M. R. The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III. J Exp Med. 1949 Jul;90(1):85–96. doi: 10.1084/jem.90.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood W. B., Irons E. N. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : II. THE EFFECT OF SULFONAMIDE THERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA. J Exp Med. 1946 Sep 30;84(4):365–376. doi: 10.1084/jem.84.4.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood W. B., McLeod C., Irons E. N. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : III. FACTORS INFLUENCING THE PHAGOCYTOSIS OF PNEUMOCOCCI IN THE LUNG DURING SULFONAMIDE THERAPY. J Exp Med. 1946 Sep 30;84(4):377–386. doi: 10.1084/jem.84.4.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood W. B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA. J Exp Med. 1941 Jan 31;73(2):201–222. doi: 10.1084/jem.73.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood W. B., Smith M. R., Watson B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : IV. THE MECHANISM OF PHAGOCYTOSIS IN THE ABSENCE OF ANTIBODY. J Exp Med. 1946 Sep 30;84(4):387–402. doi: 10.1084/jem.84.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]